Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations 
Bank of America's $72.5M Epstein Settlement: What You Need to Know 
U.S.-Iran Conflict Stalls as Diplomatic Efforts Collapse and Global Oil Tensions Rise 
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
PLS Reports Record Lithium Output as EV Demand Fuels Market Growth 
Nikkei Retreats After Brief 60,000 Break as Profit-Taking and Geopolitical Risks Weigh 
Asian Markets Mixed as Oil Prices Rise Amid Middle East Tensions and Ceasefire Uncertainty 
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident 
Meta Expands AI Training With Employee Activity Tracking Tools 
Iran-Pakistan Diplomacy and Strait of Hormuz Tensions Push Oil Prices Above $100 
Gold Prices Slip as Strong Dollar and Middle East Tensions Weigh on Market 
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
Asian Stocks Surge to Record Highs as Wall Street Rally Offsets Oil Price Concerns 
USDA Plans to Expand Farmer Surveys to Improve Crop Report Accuracy 
A US Court of Appeals revived a challenge by Johnson & Johnson unit Auris Health Inc to a patent on a robotic tool used to perform surgery held by rival Intuitive Surgical Operations Inc.
The US Patent Trial and Appeal Board (PTAB) found that the two earlier patents included all the elements of Intuitive's. However, it said the patent was not obvious because a person of ordinary skill would not have been motivated to combine them because of skepticism at the time of the invention for using robotic systems during surgery in the first place.
A panel of the US Court of Appeals for the Federal Circuit Court ruled 2-1to direct the US Patent and Trademark Office's invention tribunal to revisit its determination that the 2012 patent, which covers a technique for more readily swapping out different surgical tools on a robotic surgical arm, was not obvious.
Auris petitioned the PTAB to invalidate Intuitive's patent in 2019, stating that it was obvious in light of two previous patents by other inventors. Those patents were for a robotic surgery interface and a robotic stand that could hold numerous instruments, respectively.
Robotic surgery uses robotic arms to manipulate surgical instruments under the supervision of a human surgeon. The technique is designed to provide surgeons with more precise control than traditional surgery.
The global robotic surgery market is expected to produce $5.46 billion in 2020, according to a report by Research and Markets. Auris is seen as a serious competitor to industry leader Intuitive.
